ArticleCancer immunology, immunotherapy : CII2020

Patients' NK cell stimulation with activated plasmacytoid dendritic cells increases dinutuximab-induced neuroblastoma killing.

Assila Belounis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.